Check-Cap Ltd. (NASDAQ:MBAI) — Market Cap & Net Worth

$8.27 Million USD  · Rank #27515

Market Cap & Net Worth: Check-Cap Ltd. (MBAI)

Check-Cap Ltd. (NASDAQ:MBAI) has a market capitalization of $8.27 Million ($8.27 Million) as of July 28, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27515 globally and #5612 in its home market, demonstrating a 7.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Check-Cap Ltd.'s stock price $1.07 by its total outstanding shares 7730359 (7.73 Million). Review Check-Cap Ltd. total liabilities to assess the company's total debt and financial obligations.

Check-Cap Ltd. Market Cap History: 2025 to 2026

Check-Cap Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $12.52 Million to $8.27 Million (0.00% CAGR).

Check-Cap Ltd. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Check-Cap Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of MBAI by Market Capitalization

Companies near Check-Cap Ltd. in the global market cap rankings as of July 28, 2026.

Key companies related to Check-Cap Ltd. by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $210.22 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $138.80 Billion USD.
  • WuXi AppTec Co Ltd (SHG:603259): Ranked #598 globally with a market cap of $45.12 Billion USD ( CN¥308.32 Billion CNY).
  • IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #615 globally with a market cap of $43.83 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#90 Thermo Fisher Scientific Inc NYSE:TMO $210.22 Billion $559.53
#169 Danaher Corporation NYSE:DHR $138.80 Billion $196.50
#598 WuXi AppTec Co Ltd SHG:603259 $45.12 Billion CN¥124.66
#615 IDEXX Laboratories Inc NASDAQ:IDXX $43.83 Billion $556.20

Check-Cap Ltd. Historical Marketcap From 2025 to 2026

Between 2025 and today, Check-Cap Ltd.'s market cap moved from $12.52 Million to $ 8.27 Million, with a yearly change of 0.00%.

Year Market Cap Change (%)
2026 $8.27 Million -33.95%
2025 $12.52 Million --

End of Day Market Cap According to Different Sources

On Jul 28th, 2026 the market cap of Check-Cap Ltd. was reported to be:

Source Market Cap
Yahoo Finance $8.27 Million USD
MoneyControl $8.27 Million USD
MarketWatch $8.27 Million USD
marketcap.company $8.27 Million USD
Reuters $8.27 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Check-Cap Ltd.

NASDAQ:MBAI USA Diagnostics & Research
Market Cap
$8.27 Million
Market Cap Rank
#27515 Global
#5612 in USA
Share Price
$1.07
Change (1 day)
-2.73%
52-Week Range
$0.95 - $3.16
All Time High
$3.16
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.